1 Min Read
May 19 (Reuters) - Fortress Biotech Inc:
* Fortress Biotech says receives notice of allowance for a new patent application covering methods of administration for intravenous tramadol Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.